Medicine brand

Alzacare 21/10 Extended Releas

Donepezil Hydrochloride + Memantine Hydrochloride

  • Made by Renata PLC
  • Registered with DGDA
  • Prescription needed
  • 3 strengths and forms
  • Extended Release Capsule
  • Capsule (Extended Release)

Strengths, Packs and Prices

Prices are the maximum retail price (MRP) published by DGDA, shown per strip for tablets and capsules. Prices marked market price are from retail listings where DGDA has not published one.

StrengthFormPackPrice (MRP)
Donepezil Hydrochloride + Memantine Hydrochloride 10 mg + 21 mgDGDA 002-0985-037Extended Release CapsulePrice coming soon
Memantine + Donepezil 28 mg+10 mgCapsule (Extended Release)Price coming soon
Memantine + Donepezil 7 mg+10 mgCapsule (Extended Release)Price coming soon

Prices last checked on 12 October 2026

About the Medicine

Donepezil Hydrochloride

IndicationsDonepezil Hydrochloride is used to treat the symptoms of mild, moderate and severe dementia caused by Alzheimer's disease. It can help memory, thinking, and the ability to carry out daily activities for a time. It does not cure…

Uses, dose, side effects and precautions

Memantine Hydrochloride

IndicationsMemantine is used to treat the symptoms of moderate to severe dementia caused by Alzheimer's disease. It can help with memory, attention, thinking and the ability to carry out daily activities. It does not cure the disease or…

Uses, dose, side effects and precautions

Registration details and prices come from the public register of the Directorate General of Drug Administration (DGDA). This page is for information and does not replace advice from your doctor or pharmacist.